EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies

Melissa A Calton, Roxanne H Croze, Christian Burns, Ghezal Beliakoff, Tandis Vazin, Paul Szymanski, Christopher Schmitt, Austin Klein, Meredith Leong, Melissa Quezada, Jenny Holt, Gabe Bolender und 10 weitere

Investigative Ophthalmology & Visual Science · 02.12.2024 · 65 (14) · 1

DOI: 10.1167/iovs.65.14.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 02.12.2024. Verfasst von Melissa A Calton und 21 weiteren Autor:innen. Beteiligte Einrichtung: 4D Molecular Therapeutics, Emeryville, California, United States. Hauptthemen laut MEDLINE: Intravitreal Injections, Genetic Therapy, Dependovirus, Transgenes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intravitreal InjectionsGenetic TherapyDependovirusTransgenesGenetic VectorsAnimalsHumansDisease Models, AnimalVascular Endothelial Growth Factor AMacaca mulattaReceptors, Vascular Endothelial Growth FactorChoroidal NeovascularizationRetinal Pigment EpitheliumWet Macular DegenerationMacaca fascicularisRecombinant Fusion Proteins

Substanzen

Vascular Endothelial Growth Factor AafliberceptReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteins

Autor:innen und Institutionen

  • 4D Molecular Therapeutics, Emeryville, California, United States.
  • Sierra Eye Associates, Reno, Nevada, United States.
  • University of Nevada, Reno School of Medicine, Reno, Nevada, United States.
  • University of California, Berkeley, California, United States.

Zitieren

APA

Calton, M. A., Croze, R. H., Burns, C., Beliakoff, G., Vazin, T., Szymanski, P., Schmitt, C., Klein, A., Leong, M., Quezada, M., Holt, J., Bolender, G., Barglow, K., Khoday, D., Mason, T., Delaria, K., Hassanipour, M., Kotterman, M., Khanani, A. M., …, & Kirn, D. (2024). Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies. Investigative Ophthalmology & Visual Science, 65(14), 1. https://doi.org/10.1167/iovs.65.14.1

Vancouver

Calton MA, Croze RH, Burns C, Beliakoff G, Vazin T, Szymanski P, et al. Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies. Investigative Ophthalmology & Visual Science. 2024;65(14):1. doi:10.1167/iovs.65.14.1

BibTeX
@article{Calton2024,
  author = {Calton, Melissa A and Croze, Roxanne H and Burns, Christian and Beliakoff, Ghezal and Vazin, Tandis and Szymanski, Paul and Schmitt, Christopher and Klein, Austin and Leong, Meredith and Quezada, Melissa and Holt, Jenny and Bolender, Gabe and Barglow, Katherine and Khoday, Devi and Mason, Thomas and Delaria, Katherine and Hassanipour, Mohammad and Kotterman, Melissa and Khanani, Arshad M and Schaffer, David and Francis, Peter and Kirn, David},
  title = {Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  volume = {65},
  number = {14},
  pages = {1},
  doi = {10.1167/iovs.65.14.1}
}
Kostenlos starten →